Compounds > paroxetine

Page last updated: 2024-08-23

paroxetine and Dysthymia

paroxetine has been researched along with Dysthymia in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (6.25)	18.2507
2000's	12 (75.00)	29.6817
2010's	3 (18.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatla, R; Cameron, C; da Silva, TL; Ravindran, AV; Ravindran, LN	1
Bienfait, KL; Dicke, A; Dobkin, RD; Friedman, J; Gara, M; Marin, H; Mark, MH; Menza, M	1
Amodeo, L; Biancofiore, A; Castelli, L; Cipriani, D; Leombruni, P; Torta, R	1
Bogetto, F; Marchiaro, L; Rasetti, R; Rivoira, E; Rocca, P	1
Ewald, R; Frank, UG; Joos, AA; Kaschka, WP; König, F; Mörike, KE	1
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD	1
Ballús, C; Casais, L; De Flores, T; de la Torre, J; Gutiérrez, M; Palao, D; Quiros, G; Riesgo, Y; Rojo, L	1
Battaglia, M; Bellotti, B; Marino, C; Molteni, M; Nobile, M	1
Barrett, J; Cornell, J; Frank, E; Katon, W; Oxman, T; Sengupta, A; Sullivan, M; Williams, JW	1
Leard-Hansson, J	1
Terluin, B; van Hout, H	1
Hull, JG; Oxman, TE	1
Barrett, JE; Cornell, JE; Frank, E; Hegel, MT; Katon, W; Oxman, TE; Sengupta, AS; Sullivan, M; Williams, JW	1
Devarajan, S; Dursun, SM; Haddad, PM	1
Bellino, S; Bogetto, F; Patria, L; Revello, RB	1
Dimidjian, S; Katon, W; Schmaling, KB; Sullivan, M	1

Trials

12 trial(s) available for paroxetine and Dysthymia

Article	Year
Paroxetine in the treatment of dysthymic disorder without co-morbidities: A double-blind, placebo-controlled, flexible-dose study. Asian journal of psychiatry, 2013, Volume: 6, Issue:2 Topics: Adult; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Young Adult	2013
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:3 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Parkinson Disease; Paroxetine; Placebos; Psychiatric Status Rating Scales	2011
Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:2 Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Time Factors	2012
A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes. Psychiatry research, 2002, Oct-10, Volume: 112, Issue:2 Topics: Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Social Adjustment; Social Behavior; Sulpiride; Treatment Outcome	2002
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. Journal of affective disorders, 2000, Volume: 58, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride	2000
The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia. International clinical psychopharmacology, 2000, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2000
An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia. Journal of child and adolescent psychopharmacology, 2000,Summer, Volume: 10, Issue:2 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Dysthymic Disorder; Female; Humans; Male; Nausea; Pain; Paroxetine; Psychiatric Status Rating Scales	2000
Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. JAMA, 2000, Sep-27, Volume: 284, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Dysthymic Disorder; Family Practice; Female; Humans; Male; Paroxetine; Psychological Tests; Psychotherapy; Treatment Outcome	2000
Social support and treatment response in older depressed primary care patients. The journals of gerontology. Series B, Psychological sciences and social sciences, 2001, Volume: 56, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Primary Health Care; Problem Solving; Social Support; Treatment Outcome	2001
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. The Journal of family practice, 2001, Volume: 50, Issue:5 Topics: Adolescent; Adult; Antidepressive Agents; Depression; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Problem Solving; Psychiatric Status Rating Scales; Psychotherapy; Remission Induction; Severity of Illness Index; Treatment Outcome	2001
Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS drugs, 2002, Volume: 16, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Dysthymic Disorder; Female; Fluoxetine; Humans; Interview, Psychological; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors	2002
Response styles among patients with minor depression and dysthymia in primary care. Journal of abnormal psychology, 2002, Volume: 111, Issue:2 Topics: Adolescent; Adult; Cognitive Behavioral Therapy; Depression; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Problem Solving; Treatment Outcome	2002

Other Studies

4 other study(ies) available for paroxetine and Dysthymia

Article	Year
Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer. Pharmacopsychiatry, 1997, Volume: 30, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Blood Pressure; Central Nervous System Diseases; Clozapine; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dysthymic Disorder; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
Treatment of mild depression in elderly patients. JAMA, 2000, Dec-20, Volume: 284, Issue:23 Topics: Aged; Antidepressive Agents, Second-Generation; Dementia; Depression; Dysthymic Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2000
Treatment of mild depression in elderly patients. JAMA, 2000, Dec-20, Volume: 284, Issue:23 Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Dysthymic Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2000
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'. Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2001